Then, we knocked out Arhgef11 in 4T1 cells using the CRISPR/Cas9 system with two different sgRNAs (Supplementary Fig. 6a, b) and implanted the knockout cells into the mammary fat pads of BALB/c mice to monitor tumor growth. Here, ARHGEF11 is linked to neoplasm.